Related Articles
Serum miR‑210‑3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis
Neoadjuvant chemotherapy with gemcitabine‑based regimens improves the prognosis of node positive resectable pancreatic head cancer
Carbohydrate antigen 19‑9 as a prognostic biomarker in pancreatic neuroendocrine tumors
Fucosylated C4b‑binding protein α‑chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic ductal adenocarcinoma
Upregulated exosomic miR‑23b‑3p plays regulatory roles in the progression of pancreatic cancer